FIRST-IN-HUMAN SINGLE- AND MULTIPLE-ASCENDING DOSE STUDY OF THE ORAL FERROPORTIN INHIBITOR VIT-2763 IN HEALTHY SUBJECTS

Authors: F. Richard, J. J. van Lier, B. Roubert, T. Haboubi, U.-M. Göhring, F. Dürrenberger

Published: 2019-06-17

DOI: 10.1097/02014419-201906001-00404

Source: Full article

---

Abstract

No abstract found.